Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod
January 18, 2019 at 15:35 PM EST
The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.